Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Niemann-Pick disease.

E H Kolodny1

  • 1New York University School of Medicine, Department of Neurology, New York 10016, USA.

Current Opinion in Hematology
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Niemann-Pick disease is now classified into types A, B, C, and D based on genetic factors. Research utilizes animal models to explore therapeutic strategies and understand disease mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GM2 gangliosidosis in British Jacob sheep.

Journal of comparative pathology·2013
Same author

Pathology of GM2 gangliosidosis in Jacob sheep.

Veterinary pathology·2010
Same author

Vitamin B12-responsive severe leukoencephalopathy and autonomic dysfunction in a patient with "normal" serum B12 levels.

Journal of neurology, neurosurgery, and psychiatry·2010
Same author

Spontaneous appearance of Tay-Sachs disease in an animal model.

Molecular genetics and metabolism·2008
Same author

Very long chain acyl-CoA dehydrogenase deficiency in a pair of mildly affected monozygotic twin sister in their late fifties.

Journal of inherited metabolic disease·2007
Same author

Rapid detection of three large novel deletions of the aspartoacylase gene in non-Jewish patients with Canavan disease.

Molecular genetics and metabolism·2006
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology
  • Neuroscience

Background:

  • Niemann-Pick disease (NPD) is a lysosomal storage disorder.
  • Historically classified by histology, NPD is now subtyped based on biochemical and molecular findings.
  • Genetic discoveries include mutations in acid sphingomyelinase (ASM) for types A/B and NPC-1 for types C/D.

Purpose of the Study:

  • To review the current classification and understanding of Niemann-Pick disease.
  • To highlight the utility of animal models in NPD research.
  • To discuss ongoing therapeutic trials and pathogenetic studies.

Main Methods:

  • Biochemical and molecular genetic analysis for disease subtyping.
  • Development and utilization of animal models for Niemann-Pick disease types A and C.

Related Experiment Videos

  • Investigating therapeutic interventions such as bone marrow transplantation and gene therapy.
  • Studying cellular mechanisms, including signal transduction pathways in disease pathogenesis.

    • Main Results:

    • Identification of deficient acid sphingomyelinase in NPD types A and B.
    • Identification of deficient NPC-1 protein in NPD types C and D.
    • Established animal models for NPD types A and C.
    • Lysosphingomyelin implicated in neurological aspects of NPD type A.
    • NPC-1 protein and apolipoprotein D accumulation observed in murine NP-C brains.

    Conclusions:

    • The classification of Niemann-Pick disease has evolved significantly due to genetic and biochemical discoveries.
    • Animal models are crucial for advancing therapeutic strategies and understanding disease mechanisms.
    • Further research into signal transduction pathways is essential for comprehending NPD pathogenesis and developing targeted treatments.